Firms

Partech

signal.nfx.com

A global technology investment platform founded in 1982 with seed, venture, Africa, growth and impact strategies and offices in Paris, Berlin, Dakar, Milan and San Francisco.

Founded: —
Type: Venture capital

Funds5

Partech Impact2026-03-172026-03-17€300M
Final close; European B2B impact scale-up/growth.
Partech Africa II2024-02-192024-02-19€280M
Final close at hardcap; African technology seed–Series C. USD300m+ is approximate equivalent.
Partech Venture successor to International Ventures VII2023-12-142023-12-14—
EUR360m target; EUR180m committed at launch. Final close unverified; amount not asserted as final commitments. European Series A/B.
Partech Entrepreneur IV2022-12-052022-12-05€120M
Closed hardcap; pre-seed/seed initial EUR300k–3m checks.
Partech Growth II2021-11-302021-11-30€650M
Closed commitments above target; EUR650m originalcurrency, contemporary USD750m approximate equivalent.

Team

Investments

team@apexlogos.ai16 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities. Fund sizes and investment stages | Strategy / fund | Supported size and status | Announcement / evidence | Supported mandate | | --- | --- | --- | --- | | Partech Impact, inaugural fund | **€300 million final close**, total commitments; latest-known fund close found in this search | [Official announcement](https://partechpartners.com/news/partech-impact-secures-300m-to-scale-european-b2b-impact-tech-leaders), 2026-03-17 | European B2B impact technology at commercial maturity, commonly over €10m revenue; scale-up/growth capital. Themes include clean production, agriculture, construction, mobility, economic empowerment and digital health. | | Partech Africa II | **€280 million final close at hard cap**; release also expresses this as $300m+, an approximate USD equivalent | [Official announcement](https://partechpartners.com/news/partech-africa-ii-fund-reaches-final-close-at-hard-cap-above-300-million-expands-team-and-portfolio), 2024-02-19 | Equity rounds from seed to Series C, across African technology sectors. | | Partech Venture, successor to Partech International Ventures VII | **€360 million announced target/size, €180 million committed** as of launch; a €360m final close was not verified | [Official launch](https://partechpartners.com/news/partech-launches-its-successor-360m-venture-fund), 2023-12-14; [fund formation counsel Racine](https://www.racine.eu/wp-content/uploads/2024/01/press-release-partech-venture_vuk.pdf), 2024-01-09, explicitly describes an aim to close at €360m | 22–24 European Series A/B businesses, €1–10m recurring revenue. Software, data/AI infrastructure, cybersecurity, DevOps, vertical platforms and fintech. | | Partech Entrepreneur IV / Seed IV | **€120 million closed at hard cap** | [Official close](https://partechpartners.com/news/partech-closes-its-fourth-seed-fund-partech-entrepreneur-iv-at-120m-to-back-entrepreneurs-from-day-1), 2022-12-05 | Pre-seed and seed, about 50 teams in Europe and globally; initial €300k–€3m checks, typically reinvest through Series B. | | Partech Growth II | **€650 million commitments, closed above target**; approximately $750m in the contemporary release | [Official close](https://partechpartners.com/news/partech-announces-closing-its-second-growth-fund-partech-growth-ii-750m), 2021-11-30 | European growth-stage technology companies; this historical mandate and closing are distinct from the later Impact fund. | The live [funds page](https://partechpartners.com/funds) (undated, accessed 2026-10-06) continues to describe Seed as investing from day one globally, Venture as European Series A/B, and Africa as seed to growth. The individual strategies have different geographic and stage mandates; a single firm-wide “seed” or “growth” tag would omit substantial context. Historical fund amounts do not establish capital remaining today. Searches for newer Seed, Growth III and Venture final closes did not yield a sufficiently supported successor/final closing; the rows are latest-known in the sources checked, not a claim that no newer vehicle exists. Signal's partner ranges cannot substitute for fund mandate or size. Current strategy-specific initial check guidance on the [official funds page](https://partechpartners.com/funds) (undated, accessed 2026-10-06) is Seed €300k–€3m; Venture €5m–€12m; Africa €1m–€15m; Growth €25m–€70m, up to €100m with LP participation; Impact €10m–€25m. These are checks, not fund sizes. Africa II's 2024 announcement instead denominates its $1m–$15m initial checks in USD; preserve this source-specific currency difference. Growth II's 2021 announcement used €20m–€70m, whereas the current page starts at €25m. Venture targets European Series A/B businesses with approximately €1m–€10m ARR; Growth targets European scale-ups with approximately €10m–€100m+ revenue run rates. Funds recorded in Adex after this review: | Fund | Disclosed amount | Announcement / filing date | | --- | --- | --- | | Partech Growth II | EUR 650000000 | 2021-11-30 | | Partech Entrepreneur IV | EUR 120000000 | 2022-12-05 | | Partech Venture successor to International Ventures VII | Undisclosed / unverified | 2023-12-14 | | Partech Africa II | EUR 280000000 | 2024-02-19 | | Partech Impact | EUR 300000000 | 2026-03-17 |
team@apexlogos.ai17 hours ago
Match research 2026-10-06 / Partech / sha256:eb9f3426c08b0f2a0c7c3a24d393a4e2049feb581059b60fffa536fcdd446c4b / part 3 of 3 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. 4. Review Plumerai's lead flag, Neoplants' seed-versus-Series A label, and Remedee's missing date/stage with the primary links above. Preserve Remedee translation/currency and completion-versus-publication caveats. 5. Exact legal vehicle allocations, Partech check amounts, remaining investable capital and a complete portfolio-wide neurotech census are unavailable here. These selective examples support the research conclusion without validating every baseline participation or current employment role. 6. Fund searches included official funds/news pages and searches for newer Seed, Growth III and Venture final closings. No sufficiently supported later closings were found beyond the 2026 Impact close; recheck these before any live financial-data update. Research only: no Adex/database or MCP Patch changes were made.
team@apexlogos.ai17 hours ago
Match research 2026-10-06 / Partech / sha256:eb9f3426c08b0f2a0c7c3a24d393a4e2049feb581059b60fffa536fcdd446c4b / part 2 of 3 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. | **Plumerai** — efficient on-device computer vision models combined with cloud vision LLMs for constrained cameras, with system-level AI engineering | Partech and OTB Ventures are new co-leads of **$8.7m Series A**, 2025-09-16 | [Official Partech announcement](https://partechpartners.com/news/plumerai-raises-87m-series-a-to-connect-vision-llms-to-trillions-of-edge-devices), 2025-09-16; [OTB account](https://otb.vc/article/plumerai-bringing-vision-ai-to-millions-of-devices/), undated. Baseline incorrectly marks Partech non-lead; use the explicit co-lead evidence for later review. This is AI infrastructure/edge technology, not neurotechnology. | | **Neoplants** — engineered plants using synthetic biology to capture indoor pollutants | Partech named among participating investors in **$20m seed financing**, reported as raised October 2022 | [Forbes reporting](https://www.forbes.com/sites/johncumbers/2023/06/01/can-a-gmo-plant-become-your-latest-household-helper/), 2023-06-01, states Heartcore led. This is contributor reporting; the author discloses that Neoplants sponsored his SynBioBeta conference, so treat it as reporting with a disclosed commercial relationship. The baseline marks the sourced round Series A although this very source says seed; exact day and Partech fund/check unverified. The [official Seed strategy history](https://partechpartners.com/news/partechs-4th-seed-fund-120m-to-back-entrepreneurial-talent-from-day-1) (2022-12-05) independently names Neoplants as an investment of previous Seed funds. | Remedee Labs below also qualifies as deep tech because of its miniaturized millimeter-wave medical hardware. Ordinary portfolio SaaS, insurance or payments companies are not automatically classified as deep tech. In particular, the baseline's Thai payments-company **Beam / Beam Therapeutics** identity mismatch must not be treated as a gene-editing investment. The snapshot associates company ID `BeamTherapeutics` with [this Thai checkout/payments article](https://techcrunch.com/2022/11/15/thailands-beam-simplifies-checkout-for-social-commerce/) dated 2022-11-15; this is a baseline citation requiring record repair, not verified biotechnology evidence. ## Verified direct neurotechnology: Remedee Labs **Remedee Labs is a verified Partech firm investment**, rather than merely a partner's previous investment. The [official French funding announcement](https://remedeelabs.com/actualites/12-million-in-funding-to-accelerate-electronic-medication-breakthrough/) (body dated **2019-11-14**, page update line 2019-11-13) identifies a **Series A** led by Hardware Club, with Partech, Habert-Dassault Finance, C4 Ventures, Supernova Invest and private investors. It reports **€11m**. Partech's [2019-11-26 newsletter](https://partechpartners.com/news/partech-newsletter-1-acquisition-42m-raised-mighty-oaks-from-little-acorns-grow) independently confirms the named participation and reports **€11m ($12m)**. No Partech check amount or exact investing fund is disclosed. The technology is direct **non-invasive neuromodulation**: a wearable millimeter-wave emitter stimulates cutaneous nerve receptors, intended to induce intracerebral endorphin release for chronic pain. This is peripheral stimulation acting through neural pathways, not an EEG system, implanted brain device or brain-computer interface. The [official 2023 partnership announcement on Partech](https://partechpartners.com/news/upsa-et-la-startup-remedee-labs-annoncent-un-partenariat-pour-am%C3%A9liorer-la-qualit%C3%A9-de-vie-et-le-bien-%C3%AAtre-des-patients-atteints-de-douleurs-chroniques) (2023-02-01) explicitly describes millimeter-wave neuromodulation. Mechanism and efficacy statements here are attributed to company announcements, not an independent clinical assessment. Material contradictions require preservation: - The [English 2019 company release](https://remedeelabs.com/en/news/11-million-in-funding-to-accelerate-electronic-medication-breakthrough/) is headed **$11m**, describes a total raised amount, and says the Series A investment completed in **April 2019**; the French version says **€11m**, while Partech gives €11m/$12m. Do not silently turn the translated $11m headline into a separate financing. April is the supported completion month; November 14 is the announcement date. - The snapshot's **$12m / unknown stage / missing date** derives from the [2022-05-12 company-issued FDA designation release](https://www.prnewswire.com/news-releases/fda-grants-breakthrough-device-designation-to-remedee-labs-for-its-groundbreaking-endorphin-stimulation-solution-for-the-management-of-fibromyalgia-301545333.html). The saved source citation and company-hosted copy indicate it recalls **2019 funding**, rather than announcing a new 2022 $12m round. PRNewswire direct retrieval timed out during this resumption; firm attribution is independently established by the 2019 primary transaction release. The company-hosted [same dated release](https://remedeelabs.com/2022-06_cp_fr_la-food-drug-administration-fda-americaine-octroie-le-statut-de/) also recalls $12m raised in 2019. FDA breakthrough designation is not marketing approval. - The [separate official €12.2m funding announcement](https://remedeelabs.com/en/news/remedee-labs-is-raising-12-2m/) (October 2022 announcement according to the dated 2023 partnership release; exact publication day not visible in the accessed English page) names Generali France, HCVC, Habert Dassault, private investors, BPI and banks for the new funding. Its historical cumulative investor list includes Partech, but does **not** establish Partech's participation in that new round. Do not attribute the €12.2m round to Partech solely from the cumulative list. The [current company timeline](https://remedeelabs.com/en/company/) (undated, accessed 2026-10-06) labels the €11m financing as seed, whereas the contemporaneous 2019 funding releases call it Series A. The interrupted draft also assigned the timeline's €12.2m entry to 2019; that year attribution could not be reproduced reliably because extracted page text places year markers after event blocks. Do not use that draft interpretation as established chronology. Prefer dated transaction releases and flag the seed-versus-Series A conflict. English company pages intermittently timed out in the web reader during this pass; their actual HTML was retrieved directly to confirm the April completion text, cumulative investor list, and timeline stage labels. No additional direct neurotech investment was verified in the selected sources checked. This is a coverage limitation, not evidence of absence across Partech's full historical portfolio. General AI/edge AI and non-neural digital-health investments should remain distinct from the verified Remedee neuromodulation exposure. ## NFX verification and attribution limitations The [Signal firm page](https://signal.nfx.com/firms/partech-ventures) was reopened and directly read on 2026-10-06; it shows the legacy Partech Ventures name, founded 1982 and locations including New York, Paris, London, Amsterdam, San Francisco, Kenya and Nigeria. It is useful discovery evidence, not an independently verified current office list. The initial partial file's Omri Benayoun/Jai Choi profile check ranges are retained as prior captured starting evidence; they were not revalidated as current firm policy in this pass. The [Romain Lavault Signal investor profile](https://signal.nfx.com/investors/romain-lavault) was directly read on resumption and lists Greenlyte as March 2024 **seed/$11m**. Official investee/co-investor releases instead specify **pre-Series A/€10.5m**; keep both labels/currencies visible and prefer primary financing evidence. That profile also displays a $300m “current fund size,” $200k–$50m investment range and $200k sweet spot without a fund vintage or close source; these cannot resolve the platform's strategy-specific fund amounts. Investor-level Signal investments can mix personal, employer and historical attribution; named firm participation in the transaction sources is the basis used above. Gmail sign-in limits intro-path access. ## Concrete later Adex review notes and missing information 1. Preserve exact identity `Partech` and canonical URL https://adex.page/firms/Partech; Partech Ventures is a legacy/Signal name. Do not confuse with PAR Technology Corporation at partech.com. 2. Add dated fund-specific amounts, stage and geography mandates; retain Venture €360m as target/announced size pending a final close source. Keep close-to-€3bn platform AUM separate. Avoid adding all fund sizes together to infer current AUM. 3. Repair the Beam payments-versus-Beam Therapeutics association after reviewing the original company/round records.
team@apexlogos.ai17 hours ago
Match research 2026-10-06 / Partech / sha256:eb9f3426c08b0f2a0c7c3a24d393a4e2049feb581059b60fffa536fcdd446c4b / part 1 of 3 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. # Partech research - Exact Adex ID: `Partech` - Canonical Adex URL: https://adex.page/firms/Partech - Research date: 2026-10-06 - Status: complete; source verification and caveats recorded. ## Starting evidence The exact Adex snapshot (`_sources/Partech.adex.json`, retrieved 2026-10-06) describes a global technology investor founded in 1982 with seed, venture, Africa, growth and impact strategies, and offices in Paris, Berlin, Dakar, Milan and San Francisco. Its investor profile has no check minimum, maximum or sweet spot. It contains 148 investment participations, including Neoplants, Plumerai, Gourmey, The Exploration Company, Greenlyte Carbon Technologies and Remedee Labs; these are starting claims, not independent verification. Many round dates are missing. A visible identity error associates the Thai payments startup Beam with company name Beam Therapeutics; this must not be counted as biotechnology evidence. NFX Signal was directly readable at https://signal.nfx.com/firms/partech-ventures on 2026-10-06. It calls the firm Partech Ventures, founded 1982, and supplies a geographically broad location list including New York. The interrupted researcher also recorded team-profile claims for Omri Benayoun (General Partner; $200K sweet spot; $200K–$50M range) and Jai Choi (Partner; $500K sweet spot; $100K–$1M range). These individual profile details were not reproduced in the resumed firm-page text extraction, so retain them only as unconfirmed historical leads. These are profile-specific claims, potentially historical, and not fund sizes or a unified current check policy. Intro paths require Gmail sign-in. Official sources will govern current identity and strategy. ## Verified identity and summary Partech is a Paris-headquartered technology investment platform spanning seed, venture, Africa, growth and impact. It is a credible deep-tech investor with verified exposure to cultivated meat, carbon capture, spacecraft and efficient edge AI, and a verified direct neurotechnology investment in Remedee Labs. Its official [Impact close announcement](https://partechpartners.com/news/partech-impact-secures-300m-to-scale-european-b2b-impact-tech-leaders) (2026-03-17) lists Paris headquarters and offices in Berlin, Dakar, Dubai, Milan, Nairobi and San Francisco. Office lists vary across vintages and Signal should not override the dated official list. The same release says the platform manages close to €3 billion; this is firm-wide AUM, not a single fund. All external sources below were accessed on **2026-10-06**. Amounts for investee rounds are company financing totals, not Partech checks. Inclusion in this research does not authorize database updates. ## Fund sizes and investment stages | Strategy / fund | Supported size and status | Announcement / evidence | Supported mandate | | --- | --- | --- | --- | | Partech Impact, inaugural fund | **€300 million final close**, total commitments; latest-known fund close found in this search | [Official announcement](https://partechpartners.com/news/partech-impact-secures-300m-to-scale-european-b2b-impact-tech-leaders), 2026-03-17 | European B2B impact technology at commercial maturity, commonly over €10m revenue; scale-up/growth capital. Themes include clean production, agriculture, construction, mobility, economic empowerment and digital health. | | Partech Africa II | **€280 million final close at hard cap**; release also expresses this as $300m+, an approximate USD equivalent | [Official announcement](https://partechpartners.com/news/partech-africa-ii-fund-reaches-final-close-at-hard-cap-above-300-million-expands-team-and-portfolio), 2024-02-19 | Equity rounds from seed to Series C, across African technology sectors. | | Partech Venture, successor to Partech International Ventures VII | **€360 million announced target/size, €180 million committed** as of launch; a €360m final close was not verified | [Official launch](https://partechpartners.com/news/partech-launches-its-successor-360m-venture-fund), 2023-12-14; [fund formation counsel Racine](https://www.racine.eu/wp-content/uploads/2024/01/press-release-partech-venture_vuk.pdf), 2024-01-09, explicitly describes an aim to close at €360m | 22–24 European Series A/B businesses, €1–10m recurring revenue. Software, data/AI infrastructure, cybersecurity, DevOps, vertical platforms and fintech. | | Partech Entrepreneur IV / Seed IV | **€120 million closed at hard cap** | [Official close](https://partechpartners.com/news/partech-closes-its-fourth-seed-fund-partech-entrepreneur-iv-at-120m-to-back-entrepreneurs-from-day-1), 2022-12-05 | Pre-seed and seed, about 50 teams in Europe and globally; initial €300k–€3m checks, typically reinvest through Series B. | | Partech Growth II | **€650 million commitments, closed above target**; approximately $750m in the contemporary release | [Official close](https://partechpartners.com/news/partech-announces-closing-its-second-growth-fund-partech-growth-ii-750m), 2021-11-30 | European growth-stage technology companies; this historical mandate and closing are distinct from the later Impact fund. | The live [funds page](https://partechpartners.com/funds) (undated, accessed 2026-10-06) continues to describe Seed as investing from day one globally, Venture as European Series A/B, and Africa as seed to growth. The individual strategies have different geographic and stage mandates; a single firm-wide “seed” or “growth” tag would omit substantial context. Historical fund amounts do not establish capital remaining today. Searches for newer Seed, Growth III and Venture final closes did not yield a sufficiently supported successor/final closing; the rows are latest-known in the sources checked, not a claim that no newer vehicle exists. Signal's partner ranges cannot substitute for fund mandate or size. Current strategy-specific initial check guidance on the [official funds page](https://partechpartners.com/funds) (undated, accessed 2026-10-06) is Seed €300k–€3m; Venture €5m–€12m; Africa €1m–€15m; Growth €25m–€70m, up to €100m with LP participation; Impact €10m–€25m. These are checks, not fund sizes. Africa II's 2024 announcement instead denominates its $1m–$15m initial checks in USD; preserve this source-specific currency difference. Growth II's 2021 announcement used €20m–€70m, whereas the current page starts at €25m. Venture targets European Series A/B businesses with approximately €1m–€10m ARR; Growth targets European scale-ups with approximately €10m–€100m+ revenue run rates. ## Named previous deep-tech investments These are selective verified examples, not an audit of all 148 baseline participations. Deep-tech classification here is a research judgment grounded in the underlying technology. | Company and technology rationale | Partech attribution and financing | Sources and dates / caveats | | --- | --- | --- | | **Gourmey** — cultivated meat produced from animal cells, involving cell biology and bioprocess engineering | Named existing investor participating in **€48m Series A**, led by Earlybird | [Partech-hosted company announcement](https://partechpartners.com/news/gourmey-raises-48m-series-a-announces-europes-largest-cultivated-meat-hub), 2022-10-05. Partech's check and fund vehicle not disclosed. Its [2022-10-06 newsletter](https://partechpartners.com/news/partech-newsletter-eventful-and-event-filled-month-sink-your-teeth) instead says $48m; prefer the explicit €48m company transaction announcement and preserve the newsletter currency discrepancy. | | **The Exploration Company** — reusable Nyx spacecraft/capsule for cargo and prospective human transport | Named participant in **Series A announced 2023-02-01**; led by EQT Ventures and Red River West | [Company release reproduced by Bordeaux Finance](https://bordeaux.finance/dernieres-actualites/the-exploration-company-raises-e40-million-series-a/), 2023-02-01, body says **€40.5m** while title rounds to €40m; [transaction counsel Hogan Lovells](https://hlc.com/en/news/hogan-lovells-beraet-investoren-bei-40-mio-euro-finanzierungsrunde-von-the-exploration-company), 2023-02-08, says €40m and names Partech. Record amount precision conflict; neither number is a Partech check. | | **Greenlyte Carbon Technologies** — research-based direct air capture, recovering CO2 with hydrogen as by-product | Partech joined investor group in **€10.5m pre-Series A** | [Official investee announcement](https://www.greenlyte.tech/impact-logs/pre-seriesa), release text dated 2024-03-06, page masthead 2024-03-24; [Earlybird co-investor announcement](https://earlybird.com/perspectives/funding-climate-solutions-greenlyte-s-10-5m-pre-series-a-round), 2024-03-06, identifies Earlybird/Green Generation as co-leads and Partech participant. Preserve the release-versus-page date distinction. |
team@apexlogos.ai23 days ago
MATCH

Jean Sini Partech, venture_partner	$8M$100K – $12M	New York, New York
Jean-Marc Patouillaud Partech, managing_partner	$6M$200K – $50M	Paris, France
Magda Posluszny Partech, principal	$1M$100K – $5M	London
Tito Cookey-Gam Partech, principal	$1M$100K – $5M	Nigeria
Jai Choi Partech, partner	$500K$100K – $1M	San Francisco Bay Area
Ceasar Nyagah Partech, senior_associate	$200K$200K – $50M	Kenya
Lewam Kefela Partech, principal	$200K$200K – $50M	Kenya
Alison Imbert Partech, partner	$200K$200K – $50M	Paris, France
Andrew Whiting Partech, investor	$200K$200K – $50M	Paris, France
André François-Poncet Partech, partner	$200K$200K – $50M	Paris, France
Boris Golden Partech, general_partner	$200K$200K – $50M	Paris, France
Bruno Crémel Partech, general_partner	$200K$200K – $50M	Paris, France
Cyril Collon Partech, general_partner	$200K$200K – $50M	Paris, France
Emmanuel Delaveau Partech, general_partner	$200K$200K – $50M	Paris, France
Guillaume Nordlinger Partech, investor	$200K$200K – $50M	Paris, France
Julie Ehrmann Partech, senior_associate	$200K$200K – $50M	Paris, France
Karen Noël Partech, unknown	$200K$200K – $50M	Paris, France
Lucas Liabeuf Partech, investor	$200K$200K – $50M	Paris, France
Marie Raichvarg Partech, managing_director	$200K$200K – $50M	Paris, France
Omri Benayoun Partech, general_partner	$200K$200K – $50M	Paris, France
Philippe Collombel Partech, managing_partner	$200K$200K – $50M	Paris, France
Romain Lavault Partech, general_partner	$200K$200K – $50M	Paris, France
Réza Malekzadeh Partech, general_partner	$200K$200K – $50M	Paris, France
Sylvain Zimmer Partech, investor	$200K$200K – $50M	Paris, France
Tidjane Dème Partech, general_partner	$200K$200K – $50M	Paris, France
Victor Huberson Partech, principal	$200K$200K – $50M	Paris, France
Nicolas El Baze Partech, general_partner	$200K$200K – $50M	San Francisco Bay Area
Alexandra Eychenne Partech, Compliance & Risk Officer	—— – —
Alexandre Durrive Partech, Chief Technology Officer	—— – —
Alexis Lancien Partech, Senior Associate	—— – —
Arnaud De Keulenaer Partech, Senior Legal Counsel	—— – —
Arnaud Minvielle Partech, General Partner	—— – —
Aya Murr Partech, Senior Associate	—— – —
Benjamin Auschitzky Partech, Scaleup Success Manager	—— – —
Benoît Piquette Partech, Chief Information Officer	—— – —
Bénédicte Bouvier Partech, Personal Assistant & Building Operations Manager	—— – —
Charlie Moussey Partech, Principal	—— – —
Gwen Kim Partech, Associate	—— – —
Isabelle Tresson Partech, Communications & Marketing Lead	—— – —
Julia Najman Partech, Senior Associate	—— – —
Julie Garrigo Partech, Financial Administrative Manager	—— – —
Keji Mustapha Partech, Chief Marketing Officer	—— – —
Laura Rolland Partech, Accountant	—— – —
Lynn Hochard Partech, CFO	—— – —
Madeline Roels Partech, General Partner -Chief Compliance & Risk Officer	—— – —
Marie Benrubi Partech, Senior Associate	—— – —
Marie Montlaur Partech, Legal Counsel	—— – —
Marie-Alix Motte Partech, Community Associate	—— – —
Marine Voron Partech, Head of HR	—— – —
Matthieu Marchand Partech, Principal	—— – —
Mirja Hitzemann Partech, Scaleup Success Manager	—— – —
Mohamed Damak Partech, Senior Associate	—— – —
Moritz Steinbrecher Partech, Principal	—— – —
Paul Soulis Partech, Analyst	—— – —
Paul Vider Partech, Principal	—— – —
Pauline Lissavalid Partech, Principal	—— – —
Remi Said Partech, General Partner	—— – —
Sabrine Chahrour Partech, Senior Associate	—— – —
Samuel Monteiro Partech, Chief Sustainability Officer	—— – —
Simone Riva Partech, Partner	—— – —
Sophie Jameau Partech, Senior Events & Internal Comms Associate	—— – —
Steven Bohn Partech, Financial Controller	—— – —
Tiffany Chhoa Partech, Senior Analyst	—— – —
Vincent Previ Partech, Managing Director	—— – —
Vivien Bovard Partech, Associate	—— – —
Vladia Ballesteros Partech, Principal, Investor Relations	—— – —
Zoé Lerebourg Partech, Financial Controller	—— – —

$50M2025-01-27	Quibim	Buenavista Equity Partners, Asabys Partners, Partech, Pierre Socha, GoHub Ventures, Amadeus Capital Partners, APEX Ventures, Adara Ventures, Kfund
$30M2026-03-10	Qevlar AI	Partech, Réza Malekzadeh
$41M2026-02-18	FYLD	Partech
$3M2026-01-15	Modeinspect	Partech, Credo Ventures
$23M2025-11-10	Digitail	Gradient Ventures, Partech, Andreas Helbig, Darian Shirazi, Romain Lavault
$8M2025-09-16	Plumerai	Partech
$5M2025-09-04	Alpic	Partech
$—2025-07-22	Makersite	Partech, Planet A Ventures
$20M2025-06-18	Mercanis	Partech, Speedinvest, Magda Posluszny, Philippe Collombel
$4M2025-05-22	Carrot Credit	Partech
$—2025-05-13	Shakers	Partech
$13M2025-05-04	Money Fellows	Partech, Cyril Collon
$17M2025-04-03	Djamo	Y Combinator, Partech Africa, Mango Capital, Oikocredit, Enza Capital, Partech, Tidjane Dème
$—2025-03-25	AMBOSS	Partech
$15M2025-02-20	METYCLE	Partech, Project A Ventures, Philipp Werner
$52M2025	Nawy	HOF Capital, Partech
$—2024-11-20	KoRo	HV Capital, Partech
$40M2024-11-04	Cintoo	Partech, Omri Benayoun
$—2024-10-09	xFarm	Partech
$—2024-10-02	Formality	Partech
$12M2024-10-01	Pydantic	Sequoia, Partech Africa, Irregular Expressions, Partech
$—2024-09-25	La Solive	Partech
$16M2024-09-10	Retraced	Partech
$15M2024-07-11	Exein	Partech
€10M2024-03-06	Greenlyte Carbon Technologies	Earlybird Venture Capital, Partech
$8M2024-02-13	Groover	Partech, Alison Imbert
$—2024-01-18	MyRealTrip	Altos Ventures, Partech
$5M2023-12-14	METYCLE	Project A Ventures, Partech, Philipp Werner
$20M2023-10-23	Nomad Homes	Partech
$11M2023-10-10	Orus	Notion Capital, Partech
$7M2023-10-08	Circular	Founders Fund, AirTree, Partech Africa, January Capital, Partech
$31M2023-07-13	Prolific	Partech
$30M2023-05-02	Nomba	Khosla Ventures, Partech Africa, Shopify Ventures, Base10 Partners, Digitalis Ventures, Partech
$21M2023-04-21	Enter	Partech
$100M2023-04-04	TerraPay	Partech, Cyril Collon
$44M2023-02-01	The Exploration Company	Cherry Ventures, Partech, Vsquared Ventures, Tommy Oehl, Filip Dames
$24M2023-01-24	Memfault	Partech, Uncork Capital, Jean Sini, Jeff Clavier
$11M2023-01-12	Digitail	Atomico, Gradient Ventures, Partech, Andreas Helbig, Darian Shirazi, Romain Lavault
$31M2022-10-31	Money Fellows	Partech
€48M2022-10-05	Gourmey	Point Nine Capital, Heartcore Capital, Earlybird Venture Capital, Instacart, Partech Africa, Bpifrance, Partech, Nathan Benaich, Alison Imbert
$12M2022-08-29	Propseller	Partech
$140M2022-06-21	Platform.sh	Partech
$42M2022-06-16	Upvest	Bessemer Venture Partners, Earlybird Venture Capital, Notion Capital, Partech, Speedinvest, Charles Birnbaum, Alex Ferrara, Patrick Norris
$—2022-06-14	TestGorilla	Atomico, Balderton Capital, Notion Capital, Partech
$40M2022-06-09	Maze	Felicis, Amplify Partners, Partech, Victoria Treyger, Boris Golden
$18M2022-04-28	symmetrical.ai	Founders Fund, Target Global, Partech Africa, Inovo.vc, Fin Capital, Market One Capital, Partech
$4M2022-02-17	Freterium	Partech, Y Combinator, Partech Africa, Motier Ventures, Flexport, Swiss Founders Fund
$40M2022-02-07	Reliance Health	Partech
$—2022-01-31	Pennylane	Founders Fund, Sequoia Capital, Partech Africa, Partech
$57M2022-01-30	Pennylane	Founders Fund, Sequoia Capital, Partech Africa, Partech
$3M2022	Kenzz	Partech
$152M2021-12-14	Fresha	Partech
$110M2021-12-06	TradeDepot Inc.	Partech
$60M2021-11-23	Bitrise	Y Combinator, Partech Africa, OpenOcean, Insight Partners, Zobito, Fiedler Capital, Partech
$—2021-11-15	Lifen	Partech
$30M2021-11-14	Homebase	Y Combinator, Goodwater Capital, Foundamental, Partech Africa, Partech
$—2021-10-07	Plum	Partech
$20M2021-09-28	Nomad Homes	Partech
$15M2021-09-23	Vyne	Founder Collective, Partech
$9M2021-09-23	Ukio	Breega, Partech
$—2021-09-15	Skello	Angular Ventures, Partech
$200M2021-09-06	Wave	Founders Fund, AJU IB Investment, Partech Africa, Ribbit Capital, Stripe, FuturePlay, Partech
$—2021-09-03	Mooncard	Angular Ventures, Partech
$80M2021-09-01	CoachHub	HV Capital, Partech, RTP Global, Speedinvest, Mathias Ockenfels, Alexander Pavlov, David Kuczek, Boris Golden
$—2021-08-01	SellerX	Cherry Ventures, Felix Capital, Partech
$16M2021-07-20	Collectiv Food	Partech
$10M2021-07-14	Gourmey	Point Nine Capital, Heartcore Capital, Earlybird Venture Capital, Big Pi Ventures, Partech Africa, Eutopia, Partech, Sylvain Zimmer, Nathan Benaich, Alison Imbert
$12M2021-07-14	Tinvio	Founders Fund, Surge, Partech Africa, AppWorks, Partech
$119M2021-06-30	Rohlik	Partech
$40M2021-05-31	Zenyum	Sequoia, SEEDS Capital, Partech Africa, RTP Global, L Catterton, TNB Aura, Partech
$50M2021-05-09	StuDocu	Partech, Point Nine Capital, Passion Capital, Peak XV Partners, Spark Capital, Partech Africa
$3M2021-03-31	Tugende	Partech
$2M2021-03-17	Digitail	Gradient Ventures, Partech
$230M2021-03-02	Rohlik	Partech, Kaya VC, Omri Benayoun
$15M2021-02-25	Maze	Amplify Partners, Partech, Boris Golden
$18M2021-01-07	Pennylane	Founders Fund, Partech Africa, Partech
$110M2021	TradeDepot Inc.	Partech
$11M2020-10-08	Joko	Partech
$—2020-09-15	Medigate	Partech
$25M2020-07-16	Drover	Cherry Ventures, Partech, RTP Global, Version One Ventures
$5M2020-07-13	MadKudu	Partech
$4M2020-05-19	Pennylane	Founders Fund, Partech Africa, Kima Ventures, Partech
$12M2020-05-05	Peanut	Founders Fund, Female Founders Fund, EQT Ventures, New Enterprise Associates, Felix Capital, Partech Africa, Partech
$—2020-04-28	Glofox	Notion Capital, Partech
$5M2020-04-27	Tinvio	Founders Fund, Surge, Partech Africa, Partech
$—2020-03-03	TerraPay	Partech
$18M2020-02-26	Dahmakan	Y Combinator, Partech Africa, Rakuten Capital, White Star Capital, JIF Capital, Partech
$2M2020-01-30	Maze	Amplify Partners, Partech
$21M2020-01-14	Oviva	AlbionVC, Earlybird Venture Capital, Partech
€11M2019-11-14	Remedee Labs	Partech
$5M2019-11-13	Peanut	Founders Fund, Sweet Capital, Index Ventures, Female Founders Fund, Felix Capital, Partech Africa, Partech
$—2019-09-30	AMBOSS	Partech, Cherry Ventures
$16M2019-08-28	Bestmile	Partech
$11M2019-08-15	Commsignia	Samsung Catalyst Fund, Credo Ventures, Day One Capital, Partech, Romain Lavault
$1M2019-07-03	Joko	Partech
$—2019-07-03	Cubyn	Partech
$22M2019-06-13	Lifen	Partech
$5M2019-05-21	Dahmakan	Y Combinator, Partech Africa, UpHonest Capital, Atami Capital, Partech
$20M2019-04-11	Shedul	Partech
$15M2019-02-25	TheGuarantors	Founders Fund, Global Founders Capital, Alven, Partech Africa, White Star Capital, Silvertech Ventures, Partech, Eric Martineau-Fortin, Romain Lavault
$2M2018-12-13	LemonBox	Partech, Jai Choi
$7M2018-10-23	Resolution Games AB	Creandum, GV, Partech Africa, MizMaa, Bonnier Capital, GP Bullhound, Partech
$—2018-09-06	Yoco	Partech
$56M2018-03-19	Made.com	Partech
$7M2018-03-15	Drover	Cherry Ventures, Partech, Version One Ventures
$45M2018-01-15	NA-KD	Partech, Northzone
$14M2017-06-21	Rinse	Partech, Nicolas El Baze
$22M2017-05-23	Frontier Car Group	Balderton Capital, Partech, Daniel Waterhouse, Jai Choi
$48M2017-03-09	Viva Republica (Toss)	Altos Ventures, Bessemer Venture Partners, Partech
$24M2017-01-30	The Bouqs Company	Partech, Omri Benayoun
$2M2016-12-12	wallarm	Partech, Y Combinator, Partech Africa, Taver Capital
$—2016-10-25	TheGuarantors	Partech, White Star Capital
$13M2016-10-24	Alan	Partech
$2M2016-01-06	Xfers	Partech
$33M2015-10-29	Brandwatch	Partech, Omri Benayoun
$1M2015-09-23	Novicap	Partech
$5M2013-10-22	Teads	Partech, Elaia Partners, Elaia
$—Unknown date	Zolar	Partech
$20MUnknown date	Neoplants	Partech, Andrew Nutter
$1MUnknown date	Ava	Partech
$—Unknown date	Tugende	Partech
$—2026-02-12	Rivage	Partech
$—2025-03-24	Rockfi	Partech
$7M2025-02-12	HD	Partech
$5M2024-11-18	Socium	Breega, Partech
$—2024-07-25	Payt	Partech
$5M2024-04-02	HD	Partech
$14M2023-12-14	Smartpricing	Partech
$5M2023-09-27	Revio	Partech, Speedinvest
$33M2022-11-28	V7 Labs	Amadeus Capital Partners, Partech, Radical Ventures
$2M2022-11-15	Beam (Thailand checkout payments)	Partech
$2M2022-10-04	Easop	boldstart ventures, Partech
$50M2022-03-24	Weglot	Partech, André François-Poncet
$62M2022-02-01	Channable	Partech
$3M2021-11-17	Walkie Talkie	Breega, Partech
$3M2020-12-18	V7 Labs	Amadeus Capital Partners, Partech
$11M2020-06-25	Ubble	Breega, Partech
$—2019-11-18	Lalilo	Partech
$37M2018-06-04	Lendix	Partech
$17M2018-06-04	PerfectStay	Felix Capital, Partech
$26M2017-07-05	Push Doctor	Partech
$—2016-04-25	Lendix	Partech
$8M2016-01-07	Push Doctor	Partech
$600K2015-03-26	Pleek	Partech, Romain Lavault
$1M2013-05-20	Sensopia	Partech
$—Unknown date	WAVE MOBILE MONEY HOLDINGS INC.	Partech
$560KUnknown date	Dejbox	Partech
$14MUnknown date	SeaBubbles	Partech

Funds5

Team

Co-investing

Investments